Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing
November 19, 2024 05:27 ET
|
Ardena Holding NV.
Ardena’s Oss facility secures GMP approval for nanomedicine manufacturing, enhancing capabilities in innovative drug development.
Nanotechnology Market Is Expected To Reach a Revenue Of USD 74.9 Billion By 2033, At 34.3% CAGR: Dimension Market Research
November 11, 2024 12:05 ET
|
Dimension Market Research
New York, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Nanotechnology Market is projected to grow from USD 5.3 billion in 2024 to USD 74.9 billion by 2033, with a CAGR of 34.3%. ...
Nanomedicine Market to Hit USD 634.2 Billion by 2032; Improvements in Drug Delivery and Therapeutics Witness Rising Momentum
October 14, 2024 09:00 ET
|
SNS Insider pvt ltd
Pune, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The SNS Insider report indicates that, “Nanomedicine Market was valued at USD 223.6 billion in 2023 and is expected to reach USD 634.2 billion during the...
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
April 30, 2024 07:00 ET
|
ViaNautis Bio
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Co-Founder of Spark Therapeutics with over 20 years of industry experience to support ViaNautis Bio in its next...
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
April 30, 2024 02:00 ET
|
ViaNautis Bio
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Co-Founder of Spark Therapeutics with over 20 years of industry experience to support ViaNautis Bio in its next...
Nanomedicine Global Market to Observe Stupendous Growth at a CAGR of ~11% by 2028 | DelveInsight
January 09, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Nanomedicine Global Market to Observe Stupendous Growth at a CAGR of ~11% by 2028 | DelveInsight Nanomedicine is experiencing heightened demand,...
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines
November 13, 2023 02:00 ET
|
ViaNautis Bio
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines ViaNautis’s proprietary drug delivery platform polyNaut® is designed to deliver...
Global Nanomedicine Market Size To Grow USD 564.15 Billion by 2032 | CAGR of 12.4%
September 18, 2023 06:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Sept. 18, 2023 (GLOBE NEWSWIRE) -- The Global Nanomedicine Market Size is To Grow from USD 174.13 Billion in 2022 to USD 564.15 Billion by 2032, at a Compound Annual Growth...
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on New ‘Dendranib’ Nanomedicine Candidate at the 16th International Society of Neuroimmunology Congress (ISNI)
August 15, 2023 08:30 ET
|
Ashvattha Therapeutics
Data will showcase anti-inflammatory and immunomodulatory effects of ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, in a mouse model of multiple sclerosis REDWOOD CITY, Calif.,...
Nanomedicine Market to Reach USD 512.5 Bn by 2028, growing at a CAGR of 12.6% - Global Analysis by TMR
May 10, 2023 15:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 11, 2023 (GLOBE NEWSWIRE) -- The global nanomedicine industry was valued at USD 198.9 Bn in 2020 and to reach USD 512.5 Bn by 2028 with a CAGR of 12.6% from...